Skip to content

Clinical trials

Phase 2 Sleep Initiation and Maintenance Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sleep Initiation and Maintenance Disorders Phase: Phase 2 Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20044
20057
200612
20078
20089
20095
20101
20113
20123
20133
20141
20155
20163
20173
20182
20195
20205
20213
20227
20239
20248
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Recruiting17
Terminated8
Not yet recruiting5
Active, not recruiting3
Withdrawn3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline7
Takeda6
Idorsia Pharmaceuticals Ltd.4
Neurim Pharmaceuticals Ltd.3
Pfizer3
Stanford University3
Arena Pharmaceuticals2
Eli Lilly and Company2
Evotec Neurosciences GmbH2
H. Lundbeck A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sleep Initiation and Maintenance Disorders130
Anxiety Disorders8
Sleep Wake Disorders8
Stress Disorders, Post-Traumatic7
Pain6
Alzheimer Disease4
Multiple Sclerosis4
Parasomnias4
Alcoholism3
Chronic Pain3

Trials

Showing 51 to 75 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.